ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis

Human bladder cancer (BC) is the fourth most common cancer in the United States. Investigation of the strategies aiming to elucidate the tumor growth and metastatic pathways in BC is critical for the management of this disease. Here we found that ATG7 expression was remarkably elevated in human blad...

Full description

Bibliographic Details
Main Authors: Junlan Zhu, Yang Li, Zhongxian Tian, Xiaohui Hua, Jiayan Gu, Jingxia Li, Claire Liu, Honglei Jin, Yulei Wang, Guosong Jiang, Haishan Huang, Chuanshu Huang
Format: Article
Language:English
Published: Elsevier 2017-06-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253117301622
_version_ 1811259344273014784
author Junlan Zhu
Yang Li
Zhongxian Tian
Xiaohui Hua
Jiayan Gu
Jingxia Li
Claire Liu
Honglei Jin
Yulei Wang
Guosong Jiang
Haishan Huang
Chuanshu Huang
author_facet Junlan Zhu
Yang Li
Zhongxian Tian
Xiaohui Hua
Jiayan Gu
Jingxia Li
Claire Liu
Honglei Jin
Yulei Wang
Guosong Jiang
Haishan Huang
Chuanshu Huang
author_sort Junlan Zhu
collection DOAJ
description Human bladder cancer (BC) is the fourth most common cancer in the United States. Investigation of the strategies aiming to elucidate the tumor growth and metastatic pathways in BC is critical for the management of this disease. Here we found that ATG7 expression was remarkably elevated in human bladder urothelial carcinoma and N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN)-induced mouse invasive BC. Knockdown of ATG7 resulted in a significant inhibitory effect on tumorigenic growth of human BC cells both in vitro and in vivo by promoting p27 expression and inducing cell cycle arrest at G2/M phase. We further demonstrated that knockdown of ATG7 upregulated FOXO1 (forkhead box protein O 1) expression, which specifically promoted p27 transcription. Moreover, mechanistic studies revealed that inhibition of ATG7 stabilized ETS2 mRNA and, in turn, reduced miR-196b transcription and expression of miR-196b, which was able to bind to the 3′ UTR of FOXO1 mRNA, consequently stabilizing FOXO1 mRNA and finally promoting p27 transcription and attenuating BC tumorigenic growth. The identification of the ATG7/FOXO1/p27 mechanism for promoting BC cell growth provides significant insights into understanding the nature of BC tumorigenesis. Together with our most recent discovery of the crucial role of ATG7 in promoting BC invasion, it raises the potential for developing an ATG7-based specific therapeutic strategy for treatment of human BC patients.
first_indexed 2024-04-12T18:30:04Z
format Article
id doaj.art-2c565dc8daef452088598fa662d708c7
institution Directory Open Access Journal
issn 2162-2531
language English
last_indexed 2024-04-12T18:30:04Z
publishDate 2017-06-01
publisher Elsevier
record_format Article
series Molecular Therapy: Nucleic Acids
spelling doaj.art-2c565dc8daef452088598fa662d708c72022-12-22T03:21:07ZengElsevierMolecular Therapy: Nucleic Acids2162-25312017-06-017C29931310.1016/j.omtn.2017.04.012ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 AxisJunlan Zhu0Yang Li1Zhongxian Tian2Xiaohui Hua3Jiayan Gu4Jingxia Li5Claire Liu6Honglei Jin7Yulei Wang8Guosong Jiang9Haishan Huang10Chuanshu Huang11Zhejiang Provincial Key Laboratory for Technology and Application of Model Organisms, School of Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaZhejiang Provincial Key Laboratory for Technology and Application of Model Organisms, School of Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaZhejiang Provincial Key Laboratory for Technology and Application of Model Organisms, School of Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaZhejiang Provincial Key Laboratory for Technology and Application of Model Organisms, School of Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaZhejiang Provincial Key Laboratory for Technology and Application of Model Organisms, School of Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaNelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY 10987, USANelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY 10987, USAZhejiang Provincial Key Laboratory for Technology and Application of Model Organisms, School of Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaNelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY 10987, USANelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY 10987, USAZhejiang Provincial Key Laboratory for Technology and Application of Model Organisms, School of Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaZhejiang Provincial Key Laboratory for Technology and Application of Model Organisms, School of Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, ChinaHuman bladder cancer (BC) is the fourth most common cancer in the United States. Investigation of the strategies aiming to elucidate the tumor growth and metastatic pathways in BC is critical for the management of this disease. Here we found that ATG7 expression was remarkably elevated in human bladder urothelial carcinoma and N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN)-induced mouse invasive BC. Knockdown of ATG7 resulted in a significant inhibitory effect on tumorigenic growth of human BC cells both in vitro and in vivo by promoting p27 expression and inducing cell cycle arrest at G2/M phase. We further demonstrated that knockdown of ATG7 upregulated FOXO1 (forkhead box protein O 1) expression, which specifically promoted p27 transcription. Moreover, mechanistic studies revealed that inhibition of ATG7 stabilized ETS2 mRNA and, in turn, reduced miR-196b transcription and expression of miR-196b, which was able to bind to the 3′ UTR of FOXO1 mRNA, consequently stabilizing FOXO1 mRNA and finally promoting p27 transcription and attenuating BC tumorigenic growth. The identification of the ATG7/FOXO1/p27 mechanism for promoting BC cell growth provides significant insights into understanding the nature of BC tumorigenesis. Together with our most recent discovery of the crucial role of ATG7 in promoting BC invasion, it raises the potential for developing an ATG7-based specific therapeutic strategy for treatment of human BC patients.http://www.sciencedirect.com/science/article/pii/S2162253117301622ATG7bladder cancertumorigenic growthmiR-196bFOXO1p27
spellingShingle Junlan Zhu
Yang Li
Zhongxian Tian
Xiaohui Hua
Jiayan Gu
Jingxia Li
Claire Liu
Honglei Jin
Yulei Wang
Guosong Jiang
Haishan Huang
Chuanshu Huang
ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis
Molecular Therapy: Nucleic Acids
ATG7
bladder cancer
tumorigenic growth
miR-196b
FOXO1
p27
title ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis
title_full ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis
title_fullStr ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis
title_full_unstemmed ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis
title_short ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis
title_sort atg7 overexpression is crucial for tumorigenic growth of bladder cancer in vitro and in vivo by targeting the ets2 mirna196b foxo1 p27 axis
topic ATG7
bladder cancer
tumorigenic growth
miR-196b
FOXO1
p27
url http://www.sciencedirect.com/science/article/pii/S2162253117301622
work_keys_str_mv AT junlanzhu atg7overexpressioniscrucialfortumorigenicgrowthofbladdercancerinvitroandinvivobytargetingtheets2mirna196bfoxo1p27axis
AT yangli atg7overexpressioniscrucialfortumorigenicgrowthofbladdercancerinvitroandinvivobytargetingtheets2mirna196bfoxo1p27axis
AT zhongxiantian atg7overexpressioniscrucialfortumorigenicgrowthofbladdercancerinvitroandinvivobytargetingtheets2mirna196bfoxo1p27axis
AT xiaohuihua atg7overexpressioniscrucialfortumorigenicgrowthofbladdercancerinvitroandinvivobytargetingtheets2mirna196bfoxo1p27axis
AT jiayangu atg7overexpressioniscrucialfortumorigenicgrowthofbladdercancerinvitroandinvivobytargetingtheets2mirna196bfoxo1p27axis
AT jingxiali atg7overexpressioniscrucialfortumorigenicgrowthofbladdercancerinvitroandinvivobytargetingtheets2mirna196bfoxo1p27axis
AT claireliu atg7overexpressioniscrucialfortumorigenicgrowthofbladdercancerinvitroandinvivobytargetingtheets2mirna196bfoxo1p27axis
AT hongleijin atg7overexpressioniscrucialfortumorigenicgrowthofbladdercancerinvitroandinvivobytargetingtheets2mirna196bfoxo1p27axis
AT yuleiwang atg7overexpressioniscrucialfortumorigenicgrowthofbladdercancerinvitroandinvivobytargetingtheets2mirna196bfoxo1p27axis
AT guosongjiang atg7overexpressioniscrucialfortumorigenicgrowthofbladdercancerinvitroandinvivobytargetingtheets2mirna196bfoxo1p27axis
AT haishanhuang atg7overexpressioniscrucialfortumorigenicgrowthofbladdercancerinvitroandinvivobytargetingtheets2mirna196bfoxo1p27axis
AT chuanshuhuang atg7overexpressioniscrucialfortumorigenicgrowthofbladdercancerinvitroandinvivobytargetingtheets2mirna196bfoxo1p27axis